Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$21.91 USD
+0.85 (4.04%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $21.88 -0.03 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RIGL 21.91 +0.85(4.04%)
Will RIGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RIGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RIGL
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
Why Rigel (RIGL) Could Beat Earnings Estimates Again
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect?
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
Other News for RIGL
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and ...
RIGL Crosses Above Key Moving Average Level
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | ...
RIGL Makes Bullish Cross Above Critical Moving Average
Nuvation Bio: Judgement Day Grows Closer